🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.41
-1.01 (-1.64%)
At close: Nov 20, 2026, 4:00 PM EST
60.41
0.00 (0.00%)
After-hours: Nov 20, 2026, 4:15 PM EST

BioMarin Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
736.011,312942.84755.13724.53587.28
Short-Term Investments
-248.93194.86318.68567.01426.6
Cash & Short-Term Investments
736.011,5611,1381,0741,2921,014
Cash Growth
-50.20%37.17%5.95%-16.86%27.39%-4.83%
Receivables
1,076908.21660.54633.7461.32373.4
Inventory
1,7961,2991,2331,107894.08776.67
Other Current Assets
312.21185.78201.53141.39104.52110.44
Total Current Assets
3,9213,9533,2322,9562,7512,274
Property, Plant & Equipment
980.08991.81,0771,1121,1141,082
Long-Term Investments
-492.24521.24622.44370.34524.29
Goodwill
666.37196.2196.2196.2196.2196.2
Other Intangible Assets
4,777310.84320.98325.3338.57388.65
Long-Term Deferred Tax Assets
897.791,5091,4891,5461,5051,450
Other Long-Term Assets
327.11140.76151.9483.5698.7889.2
Total Assets
11,5697,5946,9896,8426,3756,005

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
130.72312.77235.4315.51231.24199.68
Accrued Expenses
735.88394.32331.27311.55293.53267.65
Current Portion of Long-Term Debt
658.72--493.88--
Current Portion of Leases
16.528.697.578.7810.3810.46
Current Income Taxes Payable
18.923.6712.572.6516.211.21
Current Unearned Revenue
---4.620.716.96
Other Current Liabilities
44.0739.620.1740.0436.8160.54
Total Current Liabilities
1,605759.03606.991,177588.88546.5
Long-Term Debt
3,515597.18595.14593.11,0831,079
Long-Term Leases
-37.0131.2638.1226.5133.84
Other Long-Term Liabilities
193.4113.897.5781.8173.579.69
Total Liabilities
5,3131,5071,3311,8901,7721,739

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.190.190.190.190.190.18
Additional Paid-In Capital
6,0895,9575,8025,6125,4055,192
Retained Earnings
181.66154.21-194.7-621.55-789.2-930.76
Comprehensive Income & Other
-14.86-23.9850.43-38.65-12.734.74
Shareholders' Equity
6,2566,0875,6584,9524,6034,266
Total Liabilities & Equity
11,5697,5946,9896,8426,3756,005

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4,190642.87633.971,1341,1201,123
Net Cash (Debt)
-3,454917.74503.74-60.07171.63-109.51
Net Cash Growth
-82.19%----
Net Cash Per Share
-17.904.652.56-0.310.91-0.60
Filing Date Shares Outstanding
193.69192.32190.78188.68186.53184.03
Total Common Shares Outstanding
193.68192.3190.76188.6186.25183.91
Working Capital
2,3163,1942,6251,7792,1631,728
Book Value Per Share
32.3031.6529.6626.2524.7123.19
Tangible Book Value
812.425,5805,1414,4304,0683,681
Tangible Book Value Per Share
4.1929.0226.9523.4921.8420.01
Land
-90.7890.7890.7890.7990.42
Buildings
-910.71892.48860.81819.1774.92
Machinery
-818.81789.5796.61736.25688.54
Construction In Progress
-134.9190.27100.01143.38136.74
Leasehold Improvements
-44.0444.3758.2359.5355.28
SEC Filings: 10-K · 10-Q